아지 바이오파마 보도자료 보도자료 June 30, 2020 Ajinomoto Bio-Pharma Services Introduces AJILITY Fast Track Platform for Drug Product Manufacturing 더 읽어보기 June 2, 2020 Ajinomoto Bio-Pharma Services Completes Acquisition of Granules OmniChem Joint Venture in India 더 읽어보기 May 27, 2020 Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19 더 읽어보기 May 5, 2020 Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn for Drug Product Used in COVID-19 Clinical Trials 더 읽어보기 April 30, 2020 Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services Enter into a Development Collaboration for a Novel Antibody Therapeutic 더 읽어보기 March 10, 2020 Ajinomoto Bio-Pharma Services Announces Formation of External Advisory Board 더 읽어보기 September 2, 2019 Information accompanying the revision of the consumption tax rate 더 읽어보기 August 29, 2019 Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India 더 읽어보기 April 9, 2019 Information on Service Brand Name Change 더 읽어보기 April 9, 2019 GeneDesign Joins Ajinomoto Bio-Pharma Services and Opens Oligonucleotide API Development Center 더 읽어보기 April 3, 2019 Jean-Baptiste Agnus Joins Ajinomoto Bio-Pharma Services’ Global Leadership Team as Vice President of Sales and Marketing 더 읽어보기 March 12, 2019 Ajinomoto Bio-Pharma Services Announces Capital Expansion to Fuel Growth 더 읽어보기 로딩 중…더 보기
